Markets:

Overview

News

Currencies

International

Treasuries

Guardant Health, Inc. - Common Stock (NQ:GH)

113.75 +15.56 (+15.85%)

Streaming Delayed Price Updated: 3:42 PM EDT, May 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Guardant Health, Inc. - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

21 22 Next >

Guardant Health Announces $90.7 Million Registered Direct Offering with Baillie Gifford

December 21, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

December 20, 2023

From Guardant Health, Inc.

Via Business Wire

Blood-Based Colorectal Cancer CRC Screening Market Likely to Benefit From FDA's Panel Surprise Advisory Possibility: Analyst ↗

December 20, 2023

Tuesday, Guardant Health Inc (NASDAQ: GH) announced that the FDA's Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee is tentatively scheduled to review the premarket...

Via Benzinga

S&P 500, Nasdaq Set For Weaker Open As 'FOMO' Rally Cools: Analyst Says Only 'Black Swan Could Upset Santa's Sleigh' Now ↗

December 20, 2023

Bond yields remain contained, providing a reason for traders to maintain their investments in stocks.

Via Benzinga

Topics Stocks

What 7 Analyst Ratings Have To Say About Guardant Health ↗

December 13, 2023

Via Benzinga

7 Analysts Have This to Say About Guardant Health ↗

November 13, 2023

Via Benzinga

Earnings Scheduled For November 6, 2023 ↗

November 06, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 19, 2023

Via Benzinga

Guardant Health Announces Tentative Date of FDA Advisory Panel Review of Shield™ Blood Test

December 19, 2023

From Guardant Health, Inc.

Via Business Wire

Cancer Research UK and Guardant Health Launch Collaboration to Advance Cancer Research and Clinical Development Activities

December 04, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health to present data at San Antonio Breast Cancer Symposium demonstrating utility of liquid biopsy in biomarker identification, therapy selection and residual disease detection

November 30, 2023

From Guardant Health, Inc.

Via Business Wire

The Latest Analyst Ratings for Guardant Health ↗

October 20, 2023

Via Benzinga

Why Guardant Health Stock Popped Again Today ↗

September 28, 2023

Wall Street loves this unprofitable biotech.

Via The Motley Fool

Jim Cramer: Buy This Financial Stock, 'It's Up Substantially From Where It Was In The Spring' ↗

November 28, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he remains a buyer of SoFi Technologies, Inc. (NASDAQ: SOFI).

Via Benzinga

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 15, 2023

From Guardant Health, Inc.

Via Business Wire

Why Is Cancer Blood Test-Focused Guardant Health Stock Trading Lower Today? ↗

November 15, 2023

Guardant Health Inc (NASDAQ: GH) shares are falling after the company announced it intends to appeal its verdict in the U.S.

Via Benzinga

Guardant Health to Appeal Federal District Court Verdict

November 15, 2023

From Guardant Health, Inc.

Via Business Wire

Cancer Test Firm Guardant Health Posts Smaller Than Expected Q3 Loss, Lifts Annual Sales Outlook ↗

November 07, 2023

Guardant Health Inc (NASDAQ: GH) reported Q3 revenue of $143 million, up 22% Y/Y, beating the consensus of $137.37 million

Via Benzinga

Guardant Health Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance

November 06, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Participate in Upcoming November Investor Conferences

November 03, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health, Flatiron Health Announce Integration of Guardant Genomic Profiling Tests Into OncoEMR® Platform

October 31, 2023

From Guardant Health, Inc.

Via Business Wire

Bull Of The Day: NeoGenomics ↗

October 24, 2023

NeoGenomics is a small-cap provider of cancer genetics diagnostics. They boast one of the most comprehensive oncology-focused testing menus in the world to help physicians diagnose and treat cancer.

Via Talk Markets

First results from PEGASUS trial reported at ESMO show promise for use of liquid biopsy to guide adjuvant treatment of colon cancer

October 23, 2023

From Guardant Health, Inc.

Via Business Wire

Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

October 17, 2023

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NASDAQ:GH),(NASDAQ:NTRA),(NYSE:DGX),(NASDAQ:NEO) EQNX::TICKER_END

Via FinancialNewsMedia

Guardant Health to Report Third Quarter 2023 Financial Results on November 6, 2023

October 16, 2023

From Guardant Health, Inc.

Via Business Wire

1 Beaten-Down Healthcare Stock to Buy and Hold For 10 Years ↗

October 11, 2023

This company's fight against a deadly disease could pay off.

Via The Motley Fool

Which Is the Better Cancer-Testing Healthcare Stock: Exact Sciences or Guardant Health? ↗

October 08, 2023

The oncology diagnostic companies are looking for better solutions in early cancer diagnosis.

Via The Motley Fool

Why Guardant Health Stock Jumped 15% This Week ↗

September 28, 2023

The precision oncology leader benefited from a pair of positive analyst notes this week. Here's what investors need to know.

Via The Motley Fool

Guardant Health Has 'Underlying Business Strength' Says This Bullish Analyst ↗

September 27, 2023

Shares of Guardant Health Inc (NASDAQ: GH) climbed during the premarket trading session and morning on Wednesday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023 ↗

September 28, 2023

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.